Congress Banner

Treatment Guidelines and Consensus Paper

The development and formulation of the WFSBP Treatment Guidelines and Consensus Papers are a major focus of the federation.

They are developed by the WFSBP Task Forces and provide a clear and top-quality treatment orientation for clinicians around the world.

Treatment Guidelines

Alzheimer's disease and dementias

Biological treatment of Alzheimer’s disease and other dementias (2011)

Anxiety disorders

Pharmacological treatment of anxiety, obsessive-compulsive disorder and posttraumatic stress disorder in primary care (2012)

Treatment of anxiety, obsessive-compulsive and posttraumatic
stress disorders (2008)

Bipolar disorders

Acute and longterm treatment of mixed states in bipolar disorder (2017)

Maintenance treatment of bipolar disorders (2013)

Acute bipolar depression (2010)

Treatment of acute mania (2009)

Clinical Guideline Development

WFSBP guidelines on how to grade treatment evidence for clinical guideline development (2020)

Brain stimulation treatments

Brain stimulation treatments in psychiatry (2010)

Depressive disorders

Treatment of unipolar depressive disorders, part 2: Maintenance treatment of major depressive disorder (2015)

Treatment of unipolar depressive disorders, part 1:
Acute and continuation treatment of major depressive disorder (2013)

Treatment of unipolar depressive disorders in primary care (2007)

Eating disorders

Pharmacological treatment of eating disorders (2011)

Paraphilias

Treatment of paraphilas (2010)

Treatment of paraphilias (2016)

Treatment of paraphilias (2020)

Personality disorders

Treatment of personality disorders (2007)

Schizophrenia

Management of special circumstances in the treatment of schizophrenia: Depression, suicidality, substance use disorders and pregnancy and lactation (2015)

Long-term treatment of schizophrenia and
management of antipsychotic-induced side effects (2013)

Acute treatment of schizophrenia and
management of treatment resistance (2012)

Substance use disorders

Treatment of substance use and related disorders:
Alcoholism, first revision (2017)

Treatment of substance use and related disorders:
Opioid dependence (2011)

Treatment of substance use and related disorders:
Alcoholism (2008)

Women's Mental Health

Treatment of alcohol use disorders in pregnant women (2019)

Consensus Papers

Consensus Paper related to the Task Force on Biological Markers

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias (2017)

Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms (2017)

Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics (2016)

Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics (2016)

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition (2016)

Biological markers in schizophrenia, part I: Neurophysiology (2015)

Biological markers for alcoholism (2014)

Biomarkers for attention-deficit/hyperactivity disorder (ADHD) (2012)

Biological markers in depression (2007)

The role of CSF and blood analysis in the early and differential diagnosis of dementia (2005)

Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity (2020)

Consensus Papers related to the Task Force on Genetics

Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response (2016)

Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics (2016)

Consensus Papers related to the Task Force on Men’s Mental Health

Prevention of homicidal behaviour in men with psychiatric disorders (2015)

Consensus Paper related to the Task Force on Psychopathlogy

Psychopathology in the 21^st century (2010)

Consensus Papers related to the Task Force on Unipolar depressive disorders

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement (2020)

Agitation Consensus

Assessment and management of agitation in psychiatry (2016)